Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of E2007 (Perampanel) in Refractory Partial Seizures
NCT00144690Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2005
- Primary completion
- Feb 2007
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of perampanel in epilepsy (3 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Maximum Tolerated Dose. Started Mar 2005; status: completed.
02
Drugs
perampanel
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00144690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00144690.